Drug Profile
FMP 010 vaccine
Alternative Names: FMP010/AS01B - GlaxoSmithKlineLatest Information Update: 08 Jul 2023
Price :
$50
*
At a glance
- Originator Walter Reed Army Institute of Research
- Developer GSK; Kenya Medical Research Institute; U.S. Army Medical Material Development Activity; United States Agency for International Development; Walter Reed Army Institute of Research
- Class Protein vaccines; Synthetic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Malaria
Most Recent Events
- 01 Jun 2013 Discontinued - Phase-I for Malaria (Prevention) in Kenya, USA (IM)
- 01 Jun 2011 No development reported - Phase-I for Malaria (Prevention) in Kenya, USA (IM)
- 01 Apr 2008 Phase-I clinical trials in Malaria (Prevention) in Kenya, USA (IM) (NCT00666380; NCT02458092)